Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03601741 · ClinicalTrials.gov registry record · NA
Use of Disposable Stethoscope Covers for Reduction of Stethoscope MRSA Contamination
A NA study, sponsored by NYU Langone Health.
- Completed
- Registry status
- NA
- Development phase
- 1
- Enrollment target
NCT03601741: Completed NA study, sponsored by NYU Langone Health.
NCT03601741 is a NA study that has completed, run by NYU Langone Health. The registered enrollment target is 1 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03601741, a NA study, has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 1 participants
- Enrollment target
Study Summary
This is a prospective pilot study using a randomized, controlled, single blinded, crossover trial design, evaluating the effect of daily antimicrobial stethoscope diaphragm covers versus uncovered stethoscope. Stethoscopes will be cleaned Sani-cloth germicidal disposable wipes which are effective against MRSA. Each participant will then be randomly assigned to 7 days in either the intervention or the control arm. At the end of the 7 days participants stethoscopes will be cleaned again. This will be followed by another 7 days in the arm that they are not in during the first 7 days. The primary endpoint is MRSA colony count from stethoscope diaphragms cultures at 7 days, focusing on the difference between the intervention and the control periods. The secondary endpoint is the rate of hospital acquired MRSA infection in patients treated by residents during each period.
Primary Outcome
Total CFU of each selected pathogen at 7 days compared by paired Mann-Whitney U tests, with each patient serving as their own control
Interventions
- OTHER Daily Antimicrobial Stethoscope Diaphragm Cover
- OTHER Uncovered Stethoscopes
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2018-06-08 |
| Est. Completion | 2019-04-05 |
| Phase | NA |
What the finished NCT03601741 record still lists
NCT03601741 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 1 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 2 interventions - of which Daily Antimicrobial Stethoscope Diaphragm Cover is the first listed.
NCT03601741 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03601741 about?
NCT03601741 is a clinical study titled "Use of Disposable Stethoscope Covers for Reduction of Stethoscope MRSA Contamination". This is a prospective pilot study using a randomized, controlled, single blinded, crossover trial design, evaluating the effect of daily antimicrobial stethoscope diaphragm covers versus uncovered stethoscope. Stethoscopes will be cleaned Sani-cloth germicidal disposable wipes which are effective ag...
What is the current status of trial NCT03601741?
This trial is currently completed. It is a NA study. The enrollment target is 1 participants. The study started on 2018-06-08. Estimated completion is 2019-04-05.
What interventions are being tested in trial NCT03601741?
The interventions under investigation include: Daily Antimicrobial Stethoscope Diaphragm Cover (OTHER), Uncovered Stethoscopes (OTHER).
Who is sponsoring clinical trial NCT03601741?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03601741's enrollment target sits among peer trials
1 2001st of 2000 the lowest of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI